• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏结节病中钆增强延迟磁共振成像与定量T2测量的相关性

Correlation of late gadolinium enhancement MRI and quantitative T2 measurement in cardiac sarcoidosis.

作者信息

Yang Yuesong, Safka Katherine, Graham John J, Roifman Idan, Zia Mohammad I, Wright Graham A, Balter Meyer, Dick Alexander J, Connelly Kim A

机构信息

Imaging Research and Schulich Heart Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.

出版信息

J Magn Reson Imaging. 2014 Mar;39(3):609-16. doi: 10.1002/jmri.24196. Epub 2013 May 29.

DOI:10.1002/jmri.24196
PMID:23720077
Abstract

PURPOSE

To investigate the potentially improved detection and quantification of cardiac involvement using novel late-gadolinium-enhancement (LGE) cardiac magnetic resonance imaging (MRI) and quantitative T2 measurement to achieve better myocardial tissue characterization in systemic sarcoidosis.

MATERIALS AND METHODS

Twenty-eight patients with systemic sarcoidosis underwent a cardiac magnetic resonance imaging (CMR) study on a 1.5T system. Precontrast CMR included left ventricular (LV) and right ventricular (RV) function and quantitative T2 measurement. Postcontrast LGE-MRI included inversion-recovery fast-gradient-echo (IR-FGRE) and multicontrast late-enhancement imaging (MCLE).

RESULTS

LV functional parameters were normal in all patients (LVEF=61.2±8.5%) including with cardiac involvement (LVEF=59.4±12.1%) and without (LVEF=61.7±7.5%) while the average RV function was comparatively decreased (RVEF=48.0±6.6%, P<0.0001). 21.4% of patients had cardiac involvement showing patchy or multiple focal hyperenhancement patterns in LV free wall, papillary muscles (PM), or interventricular septum. In two cases with PM involvement, the PM abnormal LGE foci were only observed on MCLE. For precontrast T2 measurements, a significantly decreased T2 measurement was observed in regions demonstrating LGE, compared to the LGE-negative group (focal LGE-positive regions vs. negative: 40.0±2.4 msec vs. 53.0±2.6 msec, P<0.0001).

CONCLUSION

LGE-MRI can identify cardiac involvement in systemic sarcoidosis. MCLE might be more sensitive at detecting subtle myocardial lesion. The decreased T2 observed in cardiac sarcoid may reflect its inactive phase, thus might provide a noninvasive method for monitoring disease activity or therapy.

摘要

目的

利用新型延迟钆增强(LGE)心脏磁共振成像(MRI)和定量T2测量,研究在系统性结节病中对心脏受累情况进行潜在改进的检测和定量分析,以实现更好的心肌组织特征描述。

材料与方法

28例系统性结节病患者在1.5T系统上接受了心脏磁共振成像(CMR)检查。对比剂注射前的CMR包括左心室(LV)和右心室(RV)功能以及定量T2测量。对比剂注射后的LGE-MRI包括反转恢复快速梯度回波(IR-FGRE)和多对比延迟增强成像(MCLE)。

结果

所有患者的LV功能参数均正常(左心室射血分数[LVEF]=61.2±8.5%),包括有心脏受累者(LVEF=59.4±12.1%)和无心脏受累者(LVEF=61.7±7.5%),而平均RV功能相对降低(右心室射血分数[RVEF]=48.0±6.6%,P<0.0001)。21.4%的患者有心脏受累,表现为LV游离壁、乳头肌(PM)或室间隔出现斑片状或多发局灶性强化模式。在2例有PM受累的病例中,仅在MCLE上观察到PM异常LGE病灶。对于对比剂注射前的T2测量,与LGE阴性组相比,在显示LGE的区域观察到T2测量值显著降低(局灶性LGE阳性区域与阴性区域:40.0±2.4毫秒对53.0±2.6毫秒,P<0.0001)。

结论

LGE-MRI可识别系统性结节病中的心脏受累情况。MCLE在检测细微心肌病变方面可能更敏感。在心脏结节病中观察到的T2降低可能反映其静止期,因此可能为监测疾病活动或治疗提供一种非侵入性方法。

相似文献

1
Correlation of late gadolinium enhancement MRI and quantitative T2 measurement in cardiac sarcoidosis.心脏结节病中钆增强延迟磁共振成像与定量T2测量的相关性
J Magn Reson Imaging. 2014 Mar;39(3):609-16. doi: 10.1002/jmri.24196. Epub 2013 May 29.
2
Papillary muscle involvement in myocardial infarction: initial results using multicontrast late-enhancement MRI.心肌梗死中乳头肌的累及:应用多对比剂晚期钆增强 MRI 的初步结果。
J Magn Reson Imaging. 2011 Jan;33(1):211-6. doi: 10.1002/jmri.22394.
3
Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis.心血管磁共振成像上广泛的延迟钆增强可预测心脏结节病患者接受类固醇治疗后的不良结局以及左心室功能改善情况欠佳。
Heart. 2014 Aug;100(15):1165-72. doi: 10.1136/heartjnl-2013-305187. Epub 2014 May 14.
4
Prognostic value of cardiovascular magnetic resonance in patients with biopsy-proven systemic sarcoidosis.活检证实的系统性肉样瘤病患者心血管磁共振的预后价值。
Eur Radiol. 2020 Jul;30(7):3702-3710. doi: 10.1007/s00330-020-06765-1. Epub 2020 Mar 12.
5
Late gadolinium enhancement in cardiac sarcoidosis: characteristic magnetic resonance findings and relationship with left ventricular function.心脏结节病的钆延迟增强:特征性磁共振表现与左心室功能的关系。
J Thorac Imaging. 2013 Jan;28(1):60-6. doi: 10.1097/RTI.0b013e3182761830.
6
CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis.CMR 成像可预测疑似心肌结节病患者的死亡和其他不良事件。
JACC Cardiovasc Imaging. 2013 Apr;6(4):501-11. doi: 10.1016/j.jcmg.2012.10.021. Epub 2013 Mar 14.
7
Multicontrast late gadolinium enhancement imaging enables viability and wall motion assessment in a single acquisition with reduced scan times.多对比剂延迟钆增强成像能够在单次采集中评估心肌存活性和室壁运动,同时缩短扫描时间。
J Magn Reson Imaging. 2009 Oct;30(4):771-7. doi: 10.1002/jmri.21907.
8
Incidence and prognostic significance of myocardial late gadolinium enhancement in patients with sarcoidosis without cardiac manifestation.心肌磁共振钆延迟增强在无心脏表现的肉状瘤病患者中的发生率和预后意义。
Chest. 2014 Oct;146(4):1064-1072. doi: 10.1378/chest.14-0139.
9
High mass (>18g) of late gadolinium enhancement on CMR imaging is associated with major cardiac events on long-term outcome in patients with biopsy-proven extracardiac sarcoidosis.心脏磁共振成像(CMR)上延迟钆增强的高负荷(>18g)与经活检证实的心脏外结节病患者长期预后中的主要心脏事件相关。
Int J Cardiol. 2016 Nov 1;222:950-956. doi: 10.1016/j.ijcard.2016.07.233. Epub 2016 Jul 30.
10
Right ventricular involvement is an important prognostic factor and risk stratification tool in suspected cardiac sarcoidosis: analysis by cardiac magnetic resonance imaging.右心室受累是疑似心脏结节病的一个重要预后因素和危险分层工具:心脏磁共振成像分析。
Clin Res Cardiol. 2020 Aug;109(8):988-998. doi: 10.1007/s00392-019-01591-y. Epub 2019 Dec 23.

引用本文的文献

1
Real-Life Utilization of Criteria Guidelines for Diagnosis of Cardiac Sarcoidosis (CS).心脏结节病(CS)诊断标准指南在实际生活中的应用
J Clin Med. 2023 Aug 14;12(16):5278. doi: 10.3390/jcm12165278.
2
Cardiac sarcoidosis involving the papillary muscle: A case report.累及乳头肌的心脏结节病:一例报告。
HeartRhythm Case Rep. 2021 Sep 3;7(12):801-805. doi: 10.1016/j.hrcr.2021.08.014. eCollection 2021 Dec.
3
Ten Questions Cardiologists Should Be Able to Answer About Cardiac Sarcoidosis: Case-Based Approach and Contemporary Review.
心脏病专家应能回答的关于心脏结节病的十个问题:基于病例的方法与当代综述
CJC Open. 2020 Dec 26;3(4):532-548. doi: 10.1016/j.cjco.2020.11.022. eCollection 2021 Apr.
4
CASPA (CArdiac Sarcoidosis in PApworth) improving the diagnosis of cardiac involvement in patients with pulmonary sarcoidosis: protocol for a prospective observational cohort study.CASPA(阿普沃思心脏结节病)改善肺结节病患者心脏受累的诊断:一项前瞻性观察队列研究方案。
BMJ Open Respir Res. 2020 Oct;7(1). doi: 10.1136/bmjresp-2020-000608.
5
Indirect pathological indicators for cardiac sarcoidosis on endomyocardial biopsy.心内膜心肌活检中心脏结节病的间接病理指标。
J Pathol Transl Med. 2020 Sep;54(5):396-410. doi: 10.4132/jptm.2020.06.10. Epub 2020 Jul 29.
6
Cardiac Magnetic Resonance Imaging for Diagnosis of Cardiac Sarcoidosis: A Meta-Analysis.心脏磁共振成像用于心脏结节病诊断的Meta分析
Can Respir J. 2018 Dec 17;2018:7457369. doi: 10.1155/2018/7457369. eCollection 2018.
7
Somatostatin receptor based hybrid imaging in sarcoidosis.基于生长抑素受体的结节病混合成像
Eur J Hybrid Imaging. 2017;1(1):7. doi: 10.1186/s41824-017-0014-y. Epub 2017 Dec 15.
8
Supplementary Diagnostic Landmarks of Left Ventricular Non-Compaction on Magnetic Resonance Imaging.磁共振成像上左心室心肌致密化不全的补充诊断标志
Yonsei Med J. 2018 Jan;59(1):63-71. doi: 10.3349/ymj.2018.59.1.63.
9
A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology.关于心脏结节病成像的联合程序立场声明:由欧洲核医学协会、欧洲心血管成像协会和美国核心脏病学会的心血管、炎症与感染委员会发布。
J Nucl Cardiol. 2018 Feb;25(1):298-319. doi: 10.1007/s12350-017-1043-4.
10
The Potential of Clinical Phenotyping of Heart Failure With Imaging Biomarkers for Guiding Therapies: A Focused Update.基于影像学标志物的心力衰竭临床表型分析对指导治疗的潜在价值:重点更新。
JACC Cardiovasc Imaging. 2017 Sep;10(9):1056-1071. doi: 10.1016/j.jcmg.2017.07.001.